Analytical Data
-
Gene name
PTER
- Application
-
Alternative Names
(Parathion hydrolase-related protein)
-
Species
Bovine
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A6QLJ8
-
Expression Region
1-349aa
-
Molecular Weight
46.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of PTER (positive regulatory domain-containing protein) recombinant proteins has emerged as a significant area of interest in molecular biology and biotechnology due to its potential implications in understanding cellular processes and disease mechanisms. PTER is involved in various regulatory functions, including gene expression, cell differentiation, and proliferation, making it a critical component in signaling pathways related to cancer and other diseases. Investigating PTER through recombinant protein technology allows for the production of large quantities of the protein, facilitating in-depth functional studies and structural analyses. Such studies are essential for elucidating the role of PTER in cellular mechanisms and its interactions with other proteins. Moreover, the generation of these recombinant proteins provides valuable tools for developing therapeutic strategies targeted at the pathways mediated by PTER. As researchers continue to explore its biological significance, the findings could lead to novel insights into disease treatment and the development of biotechnological applications, such as drug development and gene therapy. The integration of PTER studies in the broader context of proteomics and systems biology further enhances its relevance in modern biological research, emphasizing the importance of understanding protein functions in health and disease.
